Teladoc Crushes Q3 Estimates

Eric Volkman, The Motley Fool
·2-min read
Teladoc Crushes Q3 Estimates
Teladoc Crushes Q3 Estimates

A breakout stock of the coronavirus era, Teladoc Health (NYSE: TDOC) delivered a third quarter that trounced analyst estimates. The period saw the telemedicine services specialist book just under $289 million in revenue, which was more than double the Q3 2019 figure, it reported on Wednesday. The company's net loss, however, deepened to $35.9 million, from the year-ago $20.3 million.